Quantitative phase imaging supported by Raman micro-spectroscopy for identifying and quantifying changes in myeloid cells treated with proteasome inhibitor

Maria Baczewska; Milena Królikowska; Martyna Mazur; Paulina Laskowska; Zofia Dziekan; Piotr Mrówka; Wojciech Krauze; Małgorzata Kujawińska

doi:10.1117/12.2649977

16 March 2023 Quantitative phase imaging supported by Raman micro-spectroscopy for identifying and quantifying changes in myeloid cells treated with proteasome inhibitor

Maria Baczewska, Milena Królikowska, Martyna Mazur, Paulina Laskowska, Zofia Dziekan, Piotr Mrówka, Wojciech Krauze, Małgorzata Kujawińska

Author Affiliations +

Proceedings Volume 12389, Quantitative Phase Imaging IX; 1238907 (2023) https://doi.org/10.1117/12.2649977
Event: SPIE BiOS, 2023, San Francisco, California, United States

Abstract

Bortezomib is one of the most researched proteasome inhibitor drug in cancer cell research. Studying its effects, measuring and monitoring treatment response and effectiveness is a widely developing area in cancer research. The introduction of non-invasive measurement tools into the this research is a very important and desirable development, as it is a promising alternative to existing chemical tests. In our work we presented multimodal methodology connecting multiple non-invasive and label-free techniques to study effects of bortezomib on RPMI8226 cells. We connected digital holographic microscopy and holographic tomography with chemical specificity from Raman micro spectroscopy and we showed that treatment with bortezomib caused decrease of RI in the cells and their nucleolus and that changes in chemical compositions after treatment indicate cell apoptosis.

Conference Presentation

Citation Download Citation

Maria Baczewska, Milena Królikowska, Martyna Mazur, Paulina Laskowska, Zofia Dziekan, Piotr Mrówka, Wojciech Krauze, and Małgorzata Kujawińska "Quantitative phase imaging supported by Raman micro-spectroscopy for identifying and quantifying changes in myeloid cells treated with proteasome inhibitor", Proc. SPIE 12389, Quantitative Phase Imaging IX, 1238907 (16 March 2023); https://doi.org/10.1117/12.2649977

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available